{"id":"cggv:0b093295-1c7c-4526-90eb-d6a9fff1cc75v1.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"cggv:0b093295-1c7c-4526-90eb-d6a9fff1cc75_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10065","date":"2021-03-22T21:11:03.977Z","role":"Approver"},{"id":"cggv:0b093295-1c7c-4526-90eb-d6a9fff1cc75_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10065","date":"2021-03-22T21:11:16.332Z","role":"Publisher"}],"evidence":[{"id":"cggv:0b093295-1c7c-4526-90eb-d6a9fff1cc75_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:0b093295-1c7c-4526-90eb-d6a9fff1cc75_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:f70ce974-cf8a-4816-94f5-68f2f93198c3","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:8b61d678-f479-47c5-b087-95efea9f746d","type":"Finding","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"},"dc:description":"7 fetuses of 9 that died shortly before/after birth carried transgene. These fetuses were pliable, with abnormally flexible limbs, soft skull. Radiographs: short and wavy ribs, short and broad long bones, poor mineralization. The skull, rib, and long bone abnormalities and poor mineralization and death in perinatal period are characteristic of OI2 in humans.","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/2450280","type":"dc:BibliographicResource","dc:abstract":"Substitutions of single glycine residues of alpha 1(I) collagen have previously been associated with the inherited disease osteogenesis imperfecta type II. Transgenic mice bearing a mutant alpha 1(I) collagen gene into which specific glycine substitutions have been engineered show a dominant lethal phenotype characteristic of the human disease, and demonstrate that as little as 10% mutant gene expression can disrupt normal collagen function.","dc:creator":"Stacey A","dc:date":"1988","dc:title":"Perinatal lethal osteogenesis imperfecta in transgenic mice bearing an engineered mutant pro-alpha 1(I) collagen gene."},"rdfs:label":"Stacey Mouse Model"}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1,"dc:description":"Compatible phenotypes but not a definitive model due to transgene methodology."}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1},{"id":"cggv:0b093295-1c7c-4526-90eb-d6a9fff1cc75_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:0b093295-1c7c-4526-90eb-d6a9fff1cc75_ad_other_el","type":"EvidenceLine","evidence":[{"id":"cggv:2c490176-4c90-4ee3-a134-18415590acbf_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:e8c60396-145a-4a7e-b1a4-37fefa297504","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":0,"detectionMethod":"Skin fibroblasts from proband, unaffected parents and sister, and one healthy control. ","firstTestingMethod":"PCR","phenotypeFreeText":"Presented at birth with short and bowed  legs, severe flexed and abducted hips, blue sclerae, wide fontanellae, soft skull. Radiographs (not shown): poor calvarial mineralization, hypoplasia of cranial bones, generalized osteopenia, bilateral fractures of  femoral heads, thinning of long bones, S-shaped femurs and bowing of tibiae. Died at 18 months following respiratory failure.","phenotypes":["obo:HP_0000592","obo:HP_0005474","obo:HP_0001384","obo:HP_0009826","obo:HP_0000239","obo:HP_0000938","obo:HP_0002979","obo:HP_0003100"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:2c490176-4c90-4ee3-a134-18415590acbf_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:590e272b-a57b-4622-854a-90a00f775530","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.3263G>C (p.Gly1088Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA291543005"}},"paternityMaternityConfirmed":"none","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/7679635","type":"dc:BibliographicResource","dc:abstract":"In this study we describe a new dominant point mutation in COL1A1 causing a lethal form of Osteogenesis imperfecta (type II B). Dermal cultured fibroblasts from the proband were shown to produce both normal and heavily overmodified type-I collagen. The mutation introduced a local conformational perturbation, which causes abnormal exposure of arginine residues; the triple helical domain was susceptible to trypsin digestion even at 30 degrees C. The chains bearing the point mutation were poorly secreted and short-term pulse experiments showed that the extensive intracellular retention of mutant trimers also impaired the secretion of normal chains. The molecular defect was localized in a COL1A1 allele by cloning and sequencing a cDNA region corresponding to the CB6 peptide. A G to C transversion which causes the substitution in the triple helical region of Gly910 with alanine was found. The mutation also causes the disappearance of a MspI-recognition site at nucleotide 3263 of the pro alpha 1 (I) coding sequence. Restriction analysis, along with the biochemical screening of collagens, allowed us to perform prenatal diagnosis on cells from chorionic-villus sampling and to exclude the recurrence of the mutation in the sibling.","dc:creator":"Valli M","dc:date":"1993","dc:title":"Osteogenesis imperfecta and type-I collagen mutations. A lethal variant caused by a Gly910-->Ala substitution in the alpha 1 (I) chain."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/7679635","rdfs:label":"Valli Proband"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5,"dc:description":"Variant with functional evidence of impact."},{"id":"cggv:d6b08d4b-15aa-42a3-8a27-dc1204a6b621_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:d1cde78f-f22a-4ff2-8726-f44a7c3c91ee","type":"Proband","firstTestingMethod":"PCR","phenotypeFreeText":"Tentative OI2 diagnosis made at 18 weeks gestation based on ultrasounds. Full diagnosis based on consistent phenotypes in radiographs (not shown) at birth. Died 2 hours after birth.","sex":"UnknownEthnicity","variant":{"id":"cggv:d6b08d4b-15aa-42a3-8a27-dc1204a6b621_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:3777f77d-e29a-4d14-8ebc-42d77c64bb39","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.1193G>A (p.Gly398Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA291546779"}},"paternityMaternityConfirmed":"none","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/7487936","type":"dc:BibliographicResource","dc:abstract":"We identified two infants with lethal (type II) osteogenesis imperfecta (OI) who were heterozygous for mutations in the COL1A1 gene that resulted in substitutions of aspartic acid for glycine at position 220 and arginine for glycine at position 664 in the product of one COL1A1 allele in each individual. In normal age- and site-matched bone, approximately 70% (by number) of the collagen fibrils were encrusted with plate-like crystallites of hydroxyapatite. In contrast, approximately 5% (by number) of the collagen fibrils in the probands' bone contained crystallites. In contrast with normal bone, the c-axes of hydroxyapatite crystallites were sometimes poorly aligned with the long axis of fibrils obtained from OI bone. Chemical analysis showed that the OI samples contained normal amounts of calcium. The probands' bone samples contained type I collagen, overmodified type I collagen and elevated levels of type III and V collagens. On the basis of biochemical and morphological data, the fibrils in the OI samples were co-polymers of normal and mutant collagen. The results are consistent with a model of fibril mineralization in which the presence of abnormal type I collagen prevents normal collagen in the same fibril from incorporating hydroxyapatite crystallites.","dc:creator":"Culbert AA","dc:date":"1995","dc:title":"Substitutions of aspartic acid for glycine-220 and of arginine for glycine-664 in the triple helix of the pro alpha 1(I) chain of type I procollagen produce lethal osteogenesis imperfecta and disrupt the ability of collagen fibrils to incorporate crystalline hydroxyapatite."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/7487936","rdfs:label":"Culbert Proband 1"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5,"dc:description":"Variant has functional evidence supporting impact."},{"id":"cggv:d83ace79-1c49-4e2e-8405-20219a5e3e1d_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:e6b18602-a5d5-4f3e-94fa-814748d00543","type":"Proband","detectionMethod":"\"Qualified genomic DNA fragments were randomly interrupted\" and fragments were amplified with PCR before high throughput sequencing and analysis (Illumina).","firstTestingMethod":"PCR","phenotypeFreeText":"under mineralization of the calvarium, ribs with multiple fractures in a discontinuous beading pattern with normal rib parts in between callus formation, long bones of the lower extremities are broadened, deformed and shortened as a result of multiple fractures.","phenotypes":["obo:HP_0005622","obo:HP_0003026","obo:HP_0041159","obo:HP_0000923","obo:HP_0005474","obo:HP_0002757"],"secondTestingMethod":"Next generation sequencing panels","sex":"UnknownEthnicity","variant":{"id":"cggv:d83ace79-1c49-4e2e-8405-20219a5e3e1d_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:3ee13555-8487-43aa-b882-e8a7525fc7b2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.3865G>A (p.Val1289Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA8644326"}},"paternityMaternityConfirmed":"none","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/25289482","type":"dc:BibliographicResource","dc:abstract":"To describe our 2 year experience in diagnosing prenatal-onset osteogenesis imperfecta (OI) by multidisciplinary assessment.","dc:creator":"Wu Q","dc:date":"2015","dc:title":"Diagnosis of fetal osteogenesis imperfecta by multidisciplinary assessment: a retrospective study of 10 cases."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25289482","rdfs:label":"Wu Patient F5"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5,"dc:description":"Consistent phenotypes with radiographs."},{"id":"cggv:83c984e1-c7b3-4dac-88a2-e2a43c7cefd0_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:6fcebf2b-2cea-47f5-a338-84250475fe67","type":"Proband","detectionMethod":"Overlapping fragments of COL1A1 and COL1A2 were amplified, then Sanger to confirm variant.","firstTestingMethod":"PCR","phenotypeFreeText":"short, compressed tubular bones, marked diminution of calvarial mineralization, beaded ribs, varying platyspondyly, and death in the perinatal period","phenotypes":["obo:HP_0000926","obo:HP_0005474","obo:HP_0003026","obo:HP_0000923"],"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"cggv:83c984e1-c7b3-4dac-88a2-e2a43c7cefd0_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:654c7ae1-4fc1-44d4-a4b9-bd19a1239ada","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.2725_2733del (p.Pro909_Gly911del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA919856575"}},"paternityMaternityConfirmed":"none","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/11668615","type":"dc:BibliographicResource","dc:abstract":"Triple helix formation is a prerequisite for the passage of type I procollagen from the endoplasmic reticulum and secretion from the cell to form extracellular fibrils that will support mineral deposition in bone. Analysis of cDNA from 11 unrelated individuals with osteogenesis imperfecta (OI) revealed the presence of 11 novel, short in-frame deletions or duplications of three, nine, or 18 nucleotides in the helical coding regions of the COL1A1 and COL1A2 collagen genes. Triple helix formation was impaired, type I collagen alpha chains were post-translationally overmodified, and extracellular secretion was markedly reduced. With one exception, the obligate Gly-Xaa-Yaa repeat pattern of amino acids in the helical domains was not altered, but the Xaa- and Yaa position residues were out of register relative to the amino acid sequences of adjacent chains in the triple helix. Thus, the identity of these amino acids, in addition to third position glycines, is important for normal helix formation. These findings expand the known repertoire of uncommon in-frame deletions and duplications in OI, and provide insight into normal collagen biosynthesis and collagen triple helix formation.","dc:creator":"Pace JM","dc:date":"2001","dc:title":"Deletions and duplications of Gly-Xaa-Yaa triplet repeats in the triple helical domains of type I collagen chains disrupt helix formation and result in several types of osteogenesis imperfecta."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/11668615","rdfs:label":"Pace Patient 2"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5,"dc:description":"Functional evidence supporting impact."},{"id":"cggv:33f8a1d5-3dc5-440f-af21-dc35db0f27b1_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:3df16453-8115-450a-abb2-03762ae0c647","type":"Proband","detectionMethod":"Overlapping fragments of COL1A1 and COL1A2 were amplified, then Sanger to confirm variant.","firstTestingMethod":"PCR","phenotypeFreeText":"short, compressed tubular bones, marked diminution of calvarial mineralization, beaded ribs, varying platyspondyly, and death in the perinatal period","phenotypes":["obo:HP_0003026","obo:HP_0005474","obo:HP_0000926","obo:HP_0000923"],"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"cggv:33f8a1d5-3dc5-440f-af21-dc35db0f27b1_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:b79b8ee1-f67d-469a-b2ac-b082eebc67ac","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.3129_3137del (p.Pro1044_Gly1046del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA291543070"}},"paternityMaternityConfirmed":"none","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11668615"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/11668615","rdfs:label":"Pace Patient 3"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5,"dc:description":"Functional evidence supporting impact."},{"id":"cggv:c4535b19-4c39-4155-a26d-1576ec3f5145_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:c0c16c5b-6efe-4f93-b73d-4a37797a47ab","type":"Proband","detectionMethod":"Overlapping fragments of COL1A1 and COL1A2 were amplified, then Sanger to confirm variant.","firstTestingMethod":"PCR","phenotypeFreeText":"short, compressed tubular bones, marked diminution of calvarial mineralization, beaded ribs, varying platyspondyly, and death in the perinatal period","phenotypes":["obo:HP_0005474","obo:HP_0003026","obo:HP_0000926","obo:HP_0000923"],"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"cggv:c4535b19-4c39-4155-a26d-1576ec3f5145_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:02c70c83-6467-4494-b27e-482f53a4959e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.3132_3140del (p.Ala1053_Gly1055del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA291543069"}},"paternityMaternityConfirmed":"none","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11668615"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/11668615","rdfs:label":"Pace Patient 4"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5,"dc:description":"Functional evidence supporting impact."},{"id":"cggv:3dc1d227-8604-4da3-9202-1ba8e2cb4bd7_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:d95ea1b4-dbdb-42ec-bd2b-607d03f26a05","type":"Proband","detectionMethod":"\"Qualified genomic DNA fragments were randomly interrupted\" and fragments were amplified with PCR before high throughput sequencing and analysis (Illumina).","firstTestingMethod":"PCR","phenotypeFreeText":"under mineralization of the calvarium, ribs with multiple fractures in a discontinuous beading pattern with normal rib parts in between callus formation, long bones of the lower extremities are broadened, deformed and shortened as a result of multiple fractures.","phenotypes":["obo:HP_0005622","obo:HP_0000923","obo:HP_0003026","obo:HP_0002757","obo:HP_0041159","obo:HP_0005474"],"secondTestingMethod":"Next generation sequencing panels","sex":"UnknownEthnicity","variant":{"id":"cggv:3dc1d227-8604-4da3-9202-1ba8e2cb4bd7_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:e32901c9-6651-44c5-9fb1-5cc227860a39","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.1256G>A (p.Gly419Glu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400218749"}},"paternityMaternityConfirmed":"none","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25289482"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25289482","rdfs:label":"Wu Patient F4"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5,"dc:description":"Consistent phenotypes with radiographs."},{"id":"cggv:ca6639e8-d3b8-4e87-8e60-d71610a80a6a_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:da5b3d3e-d437-49c7-9695-36d9cd39bff0","type":"Proband","firstTestingMethod":"PCR","phenotypeFreeText":"Evaluation at 32 weeks revealed short limbs in ultrasound. Full OI2 diagnosis based on consistent phenotypes in radiographs (not shown) at birth. Died in immediate perinatal period.","phenotypes":"obo:HP_0009826","sex":"UnknownEthnicity","variant":{"id":"cggv:ca6639e8-d3b8-4e87-8e60-d71610a80a6a_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:15de1bc9-47e1-4611-8437-1e624b84e5e3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.2524G>C (p.Gly842Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA291543298"}},"paternityMaternityConfirmed":"none","dc:source":"https://pubmed.ncbi.nlm.nih.gov/7487936"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/7487936","rdfs:label":"Culbert Proband 2"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5,"dc:description":"Variant has functional evidence supporting impact. "},{"id":"cggv:264c11e4-cf93-49d0-9b19-f7f3752dc4e4_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:259523ec-0116-4c9b-acbc-c47a82b3216a","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":0,"detectionMethod":"Tissue samples from patient's autopsy and skin biopsies from parents. Peptide sequencing and amino acid analysis.","firstTestingMethod":"Other","sex":"Female","variant":{"id":"cggv:264c11e4-cf93-49d0-9b19-f7f3752dc4e4_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:fc21fb66-5b09-4c75-8fc5-62be6e3080e6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.3(COL1A1):c.1705G>C (p.Gly569Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA257815"}},"paternityMaternityConfirmed":"none","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/3108247","type":"dc:BibliographicResource","dc:abstract":"A baby with the lethal perinatal form of osteogenesis imperfecta was shown to have a structural defect in the alpha 1(I) chain of type I procollagen. Normal and mutant alpha 1(I) CB8 cyanogen bromide peptides, from the helical part of the alpha 1(I) chains, were purified from bone. Amino acid sequencing of tryptic peptides derived from the mutant alpha 1(I) CB8 peptide showed that the glycine residue at position 391 of the alpha 1(I) chain had been replaced by an arginine residue. This substitution accounted for the more basic charged form of this peptide that was observed on two-dimensional electrophoresis of the collagen peptides obtained from the tissues. The substitution was associated with increased enzymatic hydroxylation of lysine residues in the alpha 1(I) CB8 and the adjoining CB3 peptides but not in the carboxyl-terminal CB6 and CB7 peptides. This finding suggested that the sequence abnormality had interfered with the propagation of the triple helix across the mutant region. The abnormal collagen was not incorporated into the more insoluble fraction of bone collagen. The baby appeared to be heterozygous for the sequence abnormality and as the parents did not show any evidence of the defect it is likely that the baby had a new mutation of one allele of the pro-alpha 1(I) gene. The amino acid substitution could result from a single nucleotide mutation in the codon GGC (glycine) to produce the codon CGC (arginine).","dc:creator":"Bateman JF","dc:date":"1987","dc:title":"Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/3108247","rdfs:label":"Bateman Proband"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5,"dc:description":"No radiographs nor specific clinical report, but extensive supporting functional evidence."},{"id":"cggv:07fc8379-0aa0-4ebf-a022-0e54fa5f49fe_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:19e6d28a-ff14-4f96-a4a2-8c3fd0d96de1","type":"Proband","detectionMethod":"\"Qualified genomic DNA fragments were randomly interrupted\" and fragments were amplified with PCR before high throughput sequencing and analysis (Illumina).","firstTestingMethod":"PCR","phenotypeFreeText":"under mineralization of the calvarium, ribs with multiple fractures in a discontinuous beading pattern with normal rib parts in between callus formation, long bones of the lower extremities are broadened, deformed and shortened as a result of multiple fractures.","phenotypes":["obo:HP_0002757","obo:HP_0005622","obo:HP_0003026","obo:HP_0000923","obo:HP_0041159","obo:HP_0005474"],"secondTestingMethod":"Next generation sequencing panels","sex":"UnknownEthnicity","variant":{"id":"cggv:07fc8379-0aa0-4ebf-a022-0e54fa5f49fe_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:c214d7d0-0c5d-41f1-8feb-f8a3bc50b6e0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.2066G>A (p.Gly689Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400211868"}},"paternityMaternityConfirmed":"none","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25289482"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25289482","rdfs:label":"Wu Patient F2"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5,"dc:description":"Consistent phenotypes with radiographs."},{"id":"cggv:c2ea1255-aa8b-49ee-9f85-eebcd19e54bd_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:553d8c8f-64b7-4d6b-95c4-db12b1a08bbb","type":"Proband","detectionMethod":"Overlapping fragments of COL1A1 and COL1A2 were amplified, then Sanger to confirm variant.","firstTestingMethod":"PCR","phenotypeFreeText":"short, compressed tubular bones, marked diminution of calvarial mineralization, beaded ribs, varying platyspondyly, and death in the perinatal period","phenotypes":["obo:HP_0003026","obo:HP_0005474","obo:HP_0000926","obo:HP_0000923"],"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"cggv:c2ea1255-aa8b-49ee-9f85-eebcd19e54bd_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:a4413ff4-ad8f-45f6-b6db-350a8820192d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.3(COL1A1):c.3141_3149TCCTGGTGC[3] (p.1047_1049APG[4])","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16042995"}},"paternityMaternityConfirmed":"none","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11668615"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/11668615","rdfs:label":"Pace Patient 5"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5,"dc:description":"Functional evidence supporting impact."},{"id":"cggv:453edf4e-2eca-4632-847b-01b9649a054e_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:db1a3c6c-f2ce-4f28-9c54-4a0ef4eadaa6","type":"Proband","detectionMethod":"\"Qualified genomic DNA fragments were randomly interrupted\" and fragments were amplified with PCR before high throughput sequencing and analysis (Illumina).","firstTestingMethod":"PCR","phenotypeFreeText":"under mineralization of the calvarium, ribs with multiple fractures in a discontinuous beading pattern with normal rib parts in between callus formation, long bones of the lower extremities are broadened, deformed and shortened as a result of multiple fractures.","phenotypes":["obo:HP_0002757","obo:HP_0005622","obo:HP_0041159","obo:HP_0003026","obo:HP_0005474","obo:HP_0000923"],"secondTestingMethod":"Next generation sequencing panels","sex":"UnknownEthnicity","variant":{"id":"cggv:453edf4e-2eca-4632-847b-01b9649a054e_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:9c6493b9-edad-4023-81e6-9ab25ae5d6b5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.2083G>A (p.Gly695Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400211795"}},"paternityMaternityConfirmed":"none","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25289482"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25289482","rdfs:label":"Wu Patient F3"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5,"dc:description":"Consistent phenotypes with radiographs."}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":6},{"id":"cggv:0b093295-1c7c-4526-90eb-d6a9fff1cc75_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"cggv:4474275e-889c-4402-86e3-f045da10f468_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:6ad6adca-02b4-4005-bfe8-11c5aaf37dfb","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":0,"firstTestingMethod":"PCR","phenotypeFreeText":"Presented at birth with bowing of lower limbs, hypoplastic thorax, dysmorphic facial features: micrognathia, triangular face. Radiographs: wormian bones of the skull, slender long bones and ribs, with multiple fractures, dense transverse bands in metaphyses and fracture surfaces of the long bones, respiratory distress requiring a ventilation support, and died at age 4 months. ","phenotypes":["obo:HP_0001999","obo:HP_0002757","obo:HP_0000883","obo:HP_0003100","obo:HP_0006711","obo:HP_0000347","obo:HP_0002098","obo:HP_0000325","obo:HP_0100959","obo:HP_0002979","obo:HP_0002645"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:4474275e-889c-4402-86e3-f045da10f468_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:acc48695-8049-4ff2-ab97-d4b860633f66","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.3(COL1A1):c.4160C>T (p.Ala1387Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA261266"}},"paternityMaternityConfirmed":"none","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/21834035","type":"dc:BibliographicResource","dc:abstract":"Osteogenesis imperfecta type IIC (OI IIC) is a rare variant of lethal OI that has been considered to be an autosomal recessive trait. Twisted, slender long bones with dense metaphyseal margins and normal vertebral bodies in OI IIC contrast with crumpled, thick long bones and multiple vertebral compression fractures in OI IIA. Here, we report on two sporadic patients with classical OI IIC and a pair of siblings, with features of OI IIC but less distortion of the tubular bones (OI dense bone variant). One case with OI IIC and the sibs had novel heterozygous mutations in the C-propeptide region of COL1A1, while the second patient with clear-cut OI IIC had no mutation in this region. Histological examination in the two sporadic cases showed a network of broad, interconnected cartilaginous trabeculae with thin osseous seams in the metaphyses. These changes differed from the narrow and short metaphyseal trabeculae found in other lethal or severe cases of OI. Our experience sheds light on the genetics and etiology of OI IIC and on its phenotypic spectrum.","dc:creator":"Takagi M","dc:date":"2011","dc:title":"Heterozygous C-propeptide mutations in COL1A1: osteogenesis imperfecta type IIC and dense bone variant."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/21834035","rdfs:label":"Patient 2.1"}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":1,"dc:description":"Scored as a de novo variant (arising de novo in mosaic father) with supporting radiographs, in patient with consistent phenotypes = 1 pt."},{"id":"cggv:91ae9c97-5ed6-4f89-baa8-120fa687d60f_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:0defafaa-79a3-432e-8553-806cde544eca","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":0,"detectionMethod":"Genomic DNA from fibroblast of proband and parents, PCR to amplify region, SSCP to identify. Absent from parents.","firstTestingMethod":"SSCP","phenotypeFreeText":"Presented at birth with short bowed extremities, dark blue sclerae, and soft skull. Died 15 minutes after birth. ","phenotypes":["obo:HP_0002979","obo:HP_0005474","obo:HP_0000592","obo:HP_0009826"],"secondTestingMethod":"PCR","sex":"Male","variant":{"id":"cggv:91ae9c97-5ed6-4f89-baa8-120fa687d60f_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:1e03027f-1233-4db6-b34d-bf7c63ff5a5c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.3(COL1A1):c.2228G>T (p.Gly743Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA257893"}},"alleleOrigin":{"id":"obo:GENO_0000880"},"paternityMaternityConfirmed":"Yes","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/8100209","type":"dc:BibliographicResource","dc:abstract":"A patient with perinatal lethal osteogenesis imperfecta (OI) type II has been studied in order to identify the causative mutation. By analysis of the type I collagen produced by cultured fibroblasts from the patient, the defect was mapped to alpha 1 cyanogen bromide peptide 7, a region corresponding to 271 amino acid residues of either the alpha 1(I) or alpha 2(I) collagen chains. Polymerase chain reaction (PCR) amplification of the corresponding region of the alpha 1(I) mRNA followed by single-strand conformation polymorphism analysis of restriction enzyme digestions of the PCR products allowed further mapping of the mutation to a small region of COL1A1. A heterozygous transversion of G to T within the last glycine codon of exon 32 was identified by DNA sequence analysis. This resulted in the substitution of glycine-565 by a valine residue, disrupting the repeating Gly-Xaa-Yaa sequence that is obligatory for correct formation of the collagen molecule. The mutation was shown to have occurred de novo and is thought to result in the OI phenotype.","dc:creator":"Mackay K","dc:date":"1993","dc:title":"SSCP detection of a Gly565Val substitution in the pro alpha 1(I) collagen chain resulting in osteogenesis imperfecta type II."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/8100209","rdfs:label":"MacKay Proband"}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":1,"dc:description":"Confirmed de novo variant in patient with consistent phenotypes and with functional evidence supporting impact."},{"id":"cggv:4cb77e86-3f65-464e-a736-04e0d585592c_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:7bdae97e-fbf8-423f-9e5c-b1db775fd476","type":"Proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":0,"detectionMethod":"PCR and direct sequencing of COL1A1, COL1A2, LEPRE1, CRTAP, PPIB","firstTestingMethod":"PCR","phenotypeFreeText":"At birth: short bent limbs with long fingers and toes, multiple fractures of the long bones, hypoplastic thorax/thoracic cage, relative macrocephaly with caput membraneceum, triangular face with hypertelorism, protruding eyes, and low set, malformed ears, died shortly after birth. Postmortem radiographs: severe calvarial demineralization, small dense facial bones, dense skull base, clavicles and ribs with discontinuous beading and multiple fractures, slender twisted diaphyses of long bones, flared metaphyses of long bones with dense transverse bonds, broad gap and sclerosis of the fracture surfaces resembled those of pseudoarthrosis, irregular/sclerotic scapular, ischial, and iliac margins.","phenotypes":["obo:HP_0002694","obo:HP_0000369","obo:HP_0000316","obo:HP_0000940","obo:HP_0000256","obo:HP_0010511","obo:HP_0009826","obo:HP_0000325","obo:HP_0000520","obo:HP_0002757","obo:HP_0003015","obo:HP_0100807","obo:HP_0006711"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"cggv:4cb77e86-3f65-464e-a736-04e0d585592c_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:ff1c41a7-f71b-447e-9fae-9ef1adfdff37","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.3(COL1A1):c.4247del (p.Thr1416fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA261265"}},"alleleOrigin":{"id":"obo:GENO_0000880"},"paternityMaternityConfirmed":"none","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21834035"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/21834035","rdfs:label":"Patient 1"}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":1,"dc:description":"De novo variant in patient with consistent phenotypes and with radiographs, but no functional evidence supporting impact."},{"id":"cggv:63b3d60a-25ba-4ca6-a4f6-e36c58f7a46d_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:a03fdafe-a1d9-4748-8cdb-620b710cbcfd","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":0,"detectionMethod":"WES of proband and parents","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Presented at birth with totally soft skull, large and flat head collapsed from front to back direction, bones in occipital region were not palpable, exophthalmia, blue sclerae, disproportional growth impairment with short, bowed arms and legs, both hips were hyperflexed and turned outward.","phenotypes":["obo:HP_0000592","obo:HP_0004331","obo:HP_0002979","obo:HP_0000520","obo:HP_0008873","obo:HP_0009826","obo:HP_0001357"],"sex":"Female","variant":{"id":"cggv:63b3d60a-25ba-4ca6-a4f6-e36c58f7a46d_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:01c8a613-1bc2-407f-97a8-0431fb35336c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.2317G>T (p.Gly773Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA400209956"}},"alleleOrigin":{"id":"obo:GENO_0000880"},"paternityMaternityConfirmed":"none","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/25958000","type":"dc:BibliographicResource","dc:abstract":"Osteogenesis imperfecta (OI) comprises a clinically and genetically heterogeneous group of connective tissue disorders, characterized by low bone mass, increased bone fragility, and blue-gray eye sclera. OI often results from missense mutations in one of the conserved glycine residues present in the Gly-X-Y sequence repeats of the triple helical region of the collagen type I Î± chain, which is encoded by the COL1A1 gene. The aim of the present study is to describe the phenotype of OI II patient and a novel mutation, causing current phenotype.","dc:creator":"Maasalu K","dc:date":"2015","dc:title":"Whole-exome sequencing identifies de novo mutation in the COL1A1 gene to underlie the severe osteogenesis imperfecta."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/25958000","rdfs:label":"Maasalu Proband"}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":0.5,"dc:description":"Confirmed de novo variant in patient with consistent phenotypes."},{"id":"cggv:bba4d8b8-d96d-4aed-bb54-e46829eb0f2b_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:cce2020e-6393-4073-859a-75b38fdc018d","type":"Proband","detectionMethod":"Molecular analysis of COL1A1 and COL1A2 of proband and parents. Variant absent from parents. Mother has short stature but no COL1A1/2 variants.","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Presented at 24 weeks gestation with shortening, angulation and crumpled appearance of long bones, small chest with beading of ribs, skull deformation and hypomineralization with too-well-seen brain structure. Pregnancy was terminated. Radiograph: generalized osteopenia, decreased mineralization of the skull, and abnormal tubular bones with thin cortex and shafts, callus formation and fractures.","phenotypes":["obo:HP_0002753","obo:HP_0001363","obo:HP_0002757","obo:HP_0000938","obo:HP_0003026","obo:HP_0011314","obo:HP_0005257","obo:HP_0006367","obo:HP_0004331"],"sex":"UnknownEthnicity","variant":{"id":"cggv:bba4d8b8-d96d-4aed-bb54-e46829eb0f2b_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:823d6af3-7bba-4081-80ee-f30c1a105c9d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.4(COL1A1):c.3141TCCTGGTGC[1] (p.1047APG[2])","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA16043049"}},"alleleOrigin":{"id":"obo:GENO_0000880"},"paternityMaternityConfirmed":"none","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/22795119","type":"dc:BibliographicResource","dc:creator":"Chen CP","dc:date":"2012","dc:title":"Identification of a deletion mutation in the short flanking repeat region of exon 44 of the COL1A1 gene in a fetus with osteogenesis imperfecta type II."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/22795119","rdfs:label":"Chen Proband"}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":1,"dc:description":"Confirmed de novo variant in patient with consistent phenotypes and radiograph."},{"id":"cggv:27e71787-1acd-4800-a0a9-103a885c785f_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:28f8ff83-b556-42ec-8d93-fd35e6585c9e","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Years","detectionMethod":"Sanger of 2kb region of patient's DNA containing COL1A1 variant- cysteine residue. Confirmed absence in parents.","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"generalized growth impairment, transverse presentation, soft head, blue sclerae, short bowed legs, low set dysmorphic ears, short neck, hypoplasia of external genitalia, broad, crumpled, bowed long bones, beaded wavy ribs and clavicles, generalized osteopenia, unusual rectangular iliac bones, hypoplasia of epiglottis, ventricular septal defect, open foramen ovale, patent ductus, pyeloureteral stenosis on the right, and abdominal testes, soft/lax/friable joint capsules of hips and knees.","phenotypes":["obo:HP_0009826","obo:HP_0002979","obo:HP_0000369","obo:HP_0000470","obo:HP_0003177","obo:HP_0001629","obo:HP_0001643","obo:HP_0000592","obo:HP_0005622","obo:HP_0000811","obo:HP_0001388","obo:HP_0010560","obo:HP_0005349","obo:HP_0000938","obo:HP_0010561"],"sex":"Male","variant":{"id":"cggv:27e71787-1acd-4800-a0a9-103a885c785f_variant_evidence_item","type":"MolecularSequenceObservation","allele":{"id":"cggv:d59fea67-f925-467c-8909-808b612a990a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000088.3(COL1A1):c.3496G>T (p.Gly1166Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA257857"}},"alleleOrigin":{"id":"obo:GENO_0000880"},"paternityMaternityConfirmed":"none","dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/3016737","type":"dc:BibliographicResource","dc:abstract":"We have characterized a mutation in a pro alpha 1(I) procollagen gene (COL1A1) that results in lethal (type II) osteogenesis imperfecta. The mutation is a single base change that results in a cysteine-for-glycine substitution at position 988 of the triple-helical portion of half of the alpha 1(I) chains of type I collagen. The mutation thus disrupts the (Gly-Xaa-Yaa)n pattern necessary for triple-helix formation, where Xaa and Yaa are other amino acids. These experiments establish the minimal mutation in a type I collagen gene capable of producing lethal disease, and the lethality demonstrates a selective mechanism for the stringent maintenance of the collagen gene structure.","dc:creator":"Cohn DH","dc:date":"1986","dc:title":"Lethal osteogenesis imperfecta resulting from a single nucleotide change in one human pro alpha 1(I) collagen allele."}},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/3016737","rdfs:label":"Cohn/Steinmann Proband"}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":1.5,"dc:description":"De novo variant in individual with consistent phenotypes, radiograph, and functional evidence supporting impact."}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":6}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":2451,"specifiedBy":"GeneValidityCriteria8","strengthScore":13,"subject":{"id":"cggv:72c609a0-1801-4fb0-b3f0-416b329e30f8","type":"GeneValidityProposition","disease":"obo:MONDO_0008147","gene":"hgnc:2197","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","dc:description":"COL1A1 has been described in relation to autosomal dominant Osteogenesis Imperfecta (OI) Type I-IV. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found difference in clinical phenotypic presentation and molecular mechanism between OI Types I-IV. Therefore, the following disease entities have been split: OI Type I (OMIM: 166200), OI Type II (OMIM: 166210), OI Type III (OMIM: 259420), and OI Type IV (OMIM: 166220). OI Type II is also known as lethal OI, and is characterized by bone fragility, perinatal fractures, severe bowing of long bones, blue sclerae in some cases, undermineralization, and death in the perinatal period due to respiratory insufficiency (Sillence et al. 1979; PMID: 458828). COL1A1 variants associated with OI Type II are not always 100% predictive of the disease because of genetic modifiers, and therefore long term survival and involvement in other types of OI can be seen with certain variants implicated in this disease. Evidence supporting this gene-disease relationship includes case-level and experimental data. At least 18 unique variants (missense, in-frame deletions and duplications, and one frameshift variant not predicted to cause NMD) have been identified in OI Type II patients in 10 publications (PMIDs: 21834035, 3016737, 3108247, 7679635, 8100209, 7487936, 22795119, 25958000, 11668615, 25289482). This gene-disease association is also supported by a mouse model that is compatible with the disease phenotypes, but is not a definitive model due to its use of transgene methodology (PMID: 2450280). In summary, COL1A1 is definitively associated with autosomal dominant Osteogenesis Imperfecta Type II. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This curation was approved by the Skeletal Disorders Gene Curation Expert Panel (GCEP) on 3/3/2021.\nGene Clinical Validity Standard Operating Procedures (SOP) - Version 8.","dc:isVersionOf":{"id":"cggv:0b093295-1c7c-4526-90eb-d6a9fff1cc75"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}